senktide has been researched along with serine in 1 studies
Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (serine) | Trials (serine) | Recent Studies (post-2010) (serine) |
---|---|---|---|---|---|
292 | 1 | 50 | 23,914 | 115 | 6,084 |
Protein | Taxonomy | senktide (IC50) | serine (IC50) |
---|---|---|---|
Acetylcholinesterase | Electrophorus electricus (electric eel) | 0.015 | |
Cholinesterase | Equus caballus (horse) | 0.016 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andren, PE; Chergui, K; Svenningsson, P; Zhang, X | 1 |
1 other study(ies) available for senktide and serine
Article | Year |
---|---|
Neurokinin B/NK3 receptors exert feedback inhibition on L-DOPA actions in the 6-OHDA lesion rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Autoradiography; Behavior, Animal; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cocaine; Disease Models, Animal; Dopamine; Feedback; Functional Laterality; Gene Expression Regulation; Levodopa; Oxidopamine; Parkinson Disease; Peptide Fragments; Quinolines; Radioisotopes; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-3; Serine; Substance P; Sympatholytics; Tyrosine 3-Monooxygenase | 2008 |